tiprankstipranks
Johnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says
PremiumThe FlyJohnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says
4d ago
Johnson & Johnson price target lowered to $165 from $170 at Raymond James
Premium
The Fly
Johnson & Johnson price target lowered to $165 from $170 at Raymond James
8d ago
Johnson & Johnson price target lowered to $155 from $170 at Stifel
Premium
The Fly
Johnson & Johnson price target lowered to $155 from $170 at Stifel
8d ago
Johnson & Johnson price target lowered to $152 from $166 at Wells Fargo
PremiumThe FlyJohnson & Johnson price target lowered to $152 from $166 at Wells Fargo
8d ago
Johnson & Johnson Reports Strong 2024 Financial Results
Premium
Company Announcements
Johnson & Johnson Reports Strong 2024 Financial Results
9d ago
Needham medtech & diagnostics analyst holds analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analyst holds analyst/industry conference call
9d ago
Genmab reports 2024 net sales of Darzalex $11.67B
PremiumThe FlyGenmab reports 2024 net sales of Darzalex $11.67B
9d ago
Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02
Premium
The Fly
Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02
9d ago
Johnson & Johnson sees FY25 adjusted EPS $10.75-$10.95, consensus $10.60
Premium
The Fly
Johnson & Johnson sees FY25 adjusted EPS $10.75-$10.95, consensus $10.60
9d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100